MRI is increasingly used to assess treatment response in muscle-invasive bladder cancer (MIBC), but only qualitatively. This study evaluates the reproducibility and predictive value of quantitative apparent diffusion coefficient (ADC), thought to be a non-invasive surrogate for tumor cell density, in patients with MIBC...
J. Greidanus, Carlotta Bernabei, K. Chupetvloska et al.· Insights into Imaging· 0 citations
OBJECTIVES
To evaluate the incremental clinical value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) beyond contrast-enhanced computed tomography (CECT) for primary staging of suspected high-risk upper tract urothelial carcinoma (UTUC).
PATIENTS AND METHODS
We conducted...
R. A. G. Lijnen, J. Ringia, K. Hendricksen et al.· BJU International· 0 citations
Mature overall survival (OS) and updated progression-free survival (PFS) outcomes and an in-depth biomarker analysis are reported and highlighted CD8+PD1+ T-cells as candidate biomarkers in relation to clinical benefit from immune checkpoint blockade in advanced PeSCC.
Tynisha S. Rafael, Alberto Gil-Jimenez, L. Elst et al.· Cancer immunology research· 0 citations
Replacing a general purpose language model with an agentic retrieval augmented system over a curated clinical knowledge base substantially reduced the undertriage and dangerous miss rates.
S. Ravichandran, M. Romano, R. Corga da Silva et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.